The Company hereby informs that the Board in its meeting held on December 18, 2025, have appointed Interim Chief Financial Officer of the Company effective December 18, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
National Peroxide Ltd's Board, at its meeting on December 18, 2025, appointed Mr. Amit Goriwale as Interim Chief Financial Officer and Interim Chief Risk Officer (Key Managerial Personnel), effective the same day. Mr. Goriwale was already working with the company as Deputy Manager (Finance & Accounts), making this an internal elevation. He is a Chartered Accountant with over 6 years of experience in finance, accounting, audit, and taxation, and has previously worked with Deloitte, Network18 Group, and Lloyd Insulations. The appointment is interim in nature and will remain in force until the Board appoints a permanent CFO.
This is an internal, interim arrangement and is largely neutral for shareholders. Investors should watch for the subsequent appointment of a permanent CFO, as a prolonged interim position could signal governance or transition concerns.